S. Tolaney (Boston, MA, United States of America)

Dana-Farber Cancer Institute, Harvard Medical School

Author Of 2 Presentations

 Conference Calendar
Adjuvant treatment early HER+ in breast cancer Educational session

How low should we go? Treatment for stage I HER2+ disease (ID 29)

Lecture Time
16:50 - 17:05
Speakers
Session Name
Adjuvant treatment early HER+ in breast cancer
Room
Channel 1
Date
Sat, 08.05.2021
Time
16:30 - 17:45
CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes Industry Satellite Symposia

Future considerations on the horizon for HR+/HER2- EBC (ID 368)

Lecture Time
19:40 - 19:45
Speakers
Session Name
CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes
Room
Channel 1
Date
Wed, 05.05.2021
Time
19:00 - 20:00

Presenter Of 2 Presentations

 Conference Calendar
Adjuvant treatment early HER+ in breast cancer Educational session

How low should we go? Treatment for stage I HER2+ disease (ID 29)

Lecture Time
16:50 - 17:05
Speakers
Session Name
Adjuvant treatment early HER+ in breast cancer
Room
Channel 1
Date
Sat, 08.05.2021
Time
16:30 - 17:45
CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes Industry Satellite Symposia

Future considerations on the horizon for HR+/HER2- EBC (ID 368)

Lecture Time
19:40 - 19:45
Speakers
Session Name
CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes
Room
Channel 1
Date
Wed, 05.05.2021
Time
19:00 - 20:00

Moderator Of 1 Session

 Conference Calendar
Channel 1 Educational session

Adjuvant treatment early HER+ in breast cancer (ID 28)

Date
Sat, 08.05.2021
Time
16:30 - 17:45
Room
Channel 1
Chairs